← Back to Search

Behavioral Intervention

Sleep Stability Intervention for Type 1 Diabetes

N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
History of stroke with neurological deficits
History of restless leg syndrome
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to week 12
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study how improving sleep regularity can help people with type 1 diabetes manage their blood sugar levels and reduce their risk of cardiovascular disease. The researchers will manipulate sleep stability to better understand

Who is the study for?
This trial is for individuals with type 1 diabetes who may be experiencing cardiovascular issues due to irregular or insufficient sleep. The study aims to understand how stabilizing sleep patterns can improve heart health and blood sugar control in these patients.
What is being tested?
The intervention being tested is a 'sleep stability' program designed to help participants achieve more regular and consistent sleep patterns, which could potentially lead to better management of their diabetes and reduced risk of cardiovascular disease.
What are the potential side effects?
Since the intervention focuses on improving sleep habits, side effects are likely minimal but may include temporary changes in mood or alertness as participants adjust their sleeping routines.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a stroke that left me with lasting neurological problems.
Select...
I have a history of restless leg syndrome.
Select...
I have had a severe low blood sugar episode in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment to week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glycemic control
Glycemic status
Insulin sensitivity
Secondary study objectives
Cardiovascular outcome CIMT
Cardiovascular outcome arterial stiffness
Cardiovascular outcome blood pressure
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Sleep stability intervention

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,569,056 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,815 Previous Clinical Trials
8,161,567 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,935 Previous Clinical Trials
47,792,241 Total Patients Enrolled
~53 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top